Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety ...
The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
The following is a summary of “Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in the February 2025 issue of the International Journal of ...
Despite these limitations, the researchers believe the study confirmed the efficacy and safety of bimekizumab and brodalumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback